Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative Radiotherapy vs Chemoradiotherapy in High-Risk Head and Neck Cancer
NCT00002555Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Feb 1994
- Primary completion
- Oct 2000
- Modality
- Small Molecules
- Countries
- 10
01
Overview
Phase 3, randomised, open-label trial of cisplatin in head and neck squamous cell carcinoma (HNSCC) (2 arms), sponsored by European Organisation for Research and Treatment of Cancer. Primary endpoint: Disease-Free Survival. Started Feb 1994; status: completed.
02
Drugs
cisplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00002555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002555.